HTA225 A review of external evidence used to support survival extrapolation in assessments of cancer drugs by the National Institute for Health and Care Excellence (NICE)

Bullement, A., Critchlow, S., Stevenson, M.D. orcid.org/0000-0002-3099-9877 et al. (2 more authors) (2022) HTA225 A review of external evidence used to support survival extrapolation in assessments of cancer drugs by the National Institute for Health and Care Excellence (NICE). In: Value in Health. ISPOR Europe 2022, 06-09 Nov 2022, Vienna, Austria. Elsevier BV , S340-S340.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2022 Published by Elsevier Inc.
Keywords: Health Services and Systems; Health Sciences; Good Health and Well Being
Dates:
  • Published (online): 14 December 2022
  • Published: December 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 25 Jan 2024 16:53
Last Modified: 25 Jan 2024 16:53
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jval.2022.09.1683
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)